Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-12-22FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the fixed-dose combination diclofenac sodium and misoprostol from Mylan Pharmaceuticals Inc. The…
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis. [Phase 3]
Phase 3 trial evaluating the impact of one or two weeks of methotrexate discontinuation on the efficacy of influenza vaccination in rheumato…
-
FDA approval · 2022-12-13FDA Approved: IDACIO — Original Application (Fresenius Kabi USA, LLC)
FDA approved IDACIO (adalimumab-afcf) from Fresenius Kabi USA, LLC as a biosimilar to adalimumab (Humira) under an original Biologics Licens…
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial update for ISIS 104838, an inhibitor targeting TNF, in active rheumatoid arthritis.
-
FDA approval · 2022-11-29FDA Approved: JYLAMVO — Original Application (SHORLA ONCOLOGY INC.)
FDA approved JYLAMVO (methotrexate) under an Original Application from SHORLA ONCOLOGY INC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: The Clinical Efficacy of Immunomodulators in RA Patients [Phase 4]
Phase 4 trial update evaluating the clinical efficacy of immunomodulators in rheumatoid arthritis.
-
FDA approval · 2022-11-16FDA Approved: AZULFIDINE EN-TABS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Azulfidine En-Tabs (sulfasalazine) filed by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2022-11-15FDA Approved: CAREONE IBUPROFEN — Supplemental Application (American Sales Company)
The FDA approved a supplemental application for CAREONE IBUPROFEN (ibuprofen) filed by American Sales Company under ANDA077349.
-
FDA approval · 2022-11-09FDA Approved: DAYPRO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Daypro (oxaprozin) from Pfizer Laboratories Div Pfizer Inc, indicating an approved update re…
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: To Compare the Efficacy and Safety of Low-dose Glucocorticoids and Tofacitinib in Alleviating Moderate to High Disease Activity Rheumatoid Arthritis for 24 Weeks [Phase 4]
A Phase 4 clinical trial comparing low-dose glucocorticoids versus tofacitinib for 24 weeks in moderate to high disease activity rheumatoid …
-
FDA approval · 2022-10-28FDA Approved: NAPROXEN SODIUM — Original Application (Camber Consumer Care Inc)
FDA approved Naproxen Sodium generic from Camber Consumer Care Inc under an Original Application (ANDA211065).
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Treatments Against RA and Effect on FDG-PET/CT [Phase 4]
Phase 4 clinical trial update evaluating treatments for rheumatoid arthritis and their effect on FDG-PET/CT imaging.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA [Phase 4]
Phase 4 trial evaluating the effectiveness and safety of Yisaipu combined with Tripterygium wilfordii for active rheumatoid arthritis has be…
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial update for MSB11456 in moderately to severely active rheumatoid arthritis; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-10-21Clinical Trial Update: Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of ILV-094 in rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 1, Phase 2]
A clinical trial update reports safety and efficacy findings for FURESTEM-RA Inj. in patients with moderate to severe rheumatoid arthritis a…
-
FDA approval · 2022-10-06FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s Naproxen and Esomeprazole Magnesium as an Original Application (ANDA213699), providing a generic versi…
-
FDA approval · 2022-09-28FDA Approved: ARTHRITIS PAIN RELIEVER — Supplemental Application (Publix Super Markets Inc)
FDA approved a supplemental application for ARTHRITIS PAIN RELIEVER (diclofenac sodium) by Publix Super Markets Inc. This action approves ch…
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis [Phase 3]
A Phase 3 trial update assessing the efficacy and safety of abatacept in combination with a JAK inhibitor for refractory rheumatoid arthriti…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation [Phase 4]
A Phase 4 trial evaluating rheumatoid arthritis treatment after first anti-TNF failed or investigated, which has been terminated.
-
FDA approval · 2022-09-15FDA Approved: CELECOXIB — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved a supplemental application for a generic celecoxib product from Westminster Pharmaceuticals, expanding access under ANDA210…
-
FDA approval · 2022-09-06FDA Approved: NAPROXEN SODIUM — Supplemental Application (CVS)
The FDA approved a supplemental application for naproxen sodium sponsored by CVS.
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing PF-06410293 with Humira in combination with methotrexate for active rheumatoid arthritis has completed with results …
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA) [Phase 4]
Phase 4 trial assessing abatacept’s ability to silence anti-citrullinated protein antibody-expressing B cells in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial evaluating Januse kinase inhibition with filgotinib to silence autoreactive B cells in rheumatoid arthritis is ongo…